Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunologic Intervention of Xuebijing Injection in Patients with Sepsis
ChiCTR2100044821Phase 4Completed
- Sponsor
- North China University of Science and Technology Affiliated Hospital
- Start
- Nov 2016
- Countries
- 1
01
Overview
Phase 4 trial of xuebijing in sepsis (2 arms), sponsored by North China University of Science and Technology Affiliated Hospital. Primary endpoint: Interleukin-6 (IL-6). Started Nov 2016; status: completed.
02
Drugs
xuebijing
03
Conditions
sepsis
Beyond the preview
Go deeper on ChiCTR2100044821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044821.